V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220013576 | 220007998 | 1.7 | 72.8 | Disease modification (D) | 2018-01-23 | 2018-01-27 | Rituximab | N | null | 220030531 | RITUXIMAB |
| 220013577 | 220007999 | 1.72 | null | Curative (C) | 2015-11-13 | 2015-11-13 | Dasatinib | null | N | 220030535 | DASATINIB |
| 220013578 | 220008002 | 1.58 | 63 | Curative (C) | 2017-10-02 | 2017-11-29 | AML18 PILOT TRIAL | N | N | 220030537 | PILOT TRIAL |
| 220013579 | 220008003 | 1.8 | 64 | Curative (C) | 2015-12-20 | 2015-12-20 | AML 18 TRIAL | Y | null | 220030537 | AML18 TRIAL |
| 220013580 | 220017851 | 1.79 | 76.6 | Curative (C) | 2015-08-01 | 2015-08-01 | AML 18 TRIAL | 1 | null | 220030541 | AML18 TRIAL |
| 220013581 | 220008007 | 1.52 | 62 | Curative (C) | 2014-02-21 | 2014-02-26 | AML 18 TRIAL | N | N | 220030541 | AML18 TRIAL |
| 220013582 | 220008008 | 1.76 | 94.1 | Adjuvant (A) | 2015-11-26 | 2015-12-02 | Dasatinib | 2 | Y | 220030550 | DASATINIB |
| 220013583 | 220008009 | 1.86 | 97 | Curative (C) | 2015-04-17 | 2015-04-24 | Rituximab | N | null | 220030556 | RITUXIMAB |
| 220013584 | 220008010 | 1.65 | 61.2 | null | 2014-06-10 | 2014-08-20 | AML18 PILOT TRIAL | 1 | N | 220030561 | PILOT TRIAL |
| 220013585 | 220008013 | 1.69 | 52.85 | Disease modification (D) | null | 2017-05-17 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 220030562 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013586 | 220008014 | null | null | null | null | 2017-06-05 | Rituximab | 02 | N | 220030565 | RITUXIMAB |
| 220013587 | 220008018 | 1.59 | 71.45 | Curative (C) | 2014-11-29 | 2014-12-03 | AML 18 TRIAL | 01 | N | 220030571 | AML18 TRIAL |
| 220013588 | 220008021 | 1.6 | 57 | null | 2016-05-06 | 2016-05-11 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 220030573 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013589 | 220014391 | 1.57 | 89.3 | Disease modification (D) | 2014-06-24 | 2014-07-07 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030584 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013591 | 220008025 | 1.76 | null | Palliative (P) | 2015-05-17 | 2015-08-06 | Rituximab | 2 | N | 220030586 | RITUXIMAB |
| 220013592 | 220014393 | 0 | null | Palliative (P) | 2013-10-09 | 2014-03-01 | Dasatinib | 02 | Y | 220030587 | DASATINIB |
| 220013593 | 220017853 | null | 95.2 | Curative (C) | 2017-06-02 | 2017-06-02 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030588 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013594 | 220008026 | 0 | 68.5 | Curative (C) | 2015-01-30 | 2015-01-30 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030590 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013595 | 220014394 | null | 121.1 | Curative (C) | 2013-05-04 | 2013-05-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030593 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013596 | 220014394 | 0 | 50.3 | Curative (C) | 2013-12-28 | 2013-12-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030593 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013597 | 220008027 | 1.67 | 71.8 | null | 2015-05-18 | 2015-08-22 | AML18 PILOT TRIAL | Y | N | 220030597 | PILOT TRIAL |
| 220013598 | 220008028 | null | null | Palliative (P) | 2016-08-15 | 2016-08-27 | Dasatinib | N | N | 220030600 | DASATINIB |
| 220013599 | 220008029 | null | null | Disease modification (D) | 2013-10-25 | 2013-10-25 | Dasatinib | N | N | 220030600 | DASATINIB |
| 220013600 | 220008029 | 1.75 | 87 | Disease modification (D) | 2017-07-17 | 2017-08-30 | AML18 PILOT TRIAL | 02 | N | 220030600 | PILOT TRIAL |
| 220013601 | 220008029 | 0 | 90 | Disease modification (D) | 2015-11-19 | 2015-11-24 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030600 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013602 | 220008029 | null | 84 | Disease modification (D) | 2016-07-12 | 2016-07-12 | Dasatinib | Y | N | 220030600 | DASATINIB |
| 220013604 | 220008031 | 0 | 61 | Curative (C) | 2014-11-07 | 2014-11-08 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030628 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013606 | 220008033 | null | 79.2 | Curative (C) | 2014-10-22 | 2014-11-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220030630 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013607 | 220008038 | 1.77 | 60 | Curative (C) | 2015-06-17 | 2015-06-24 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | 220030633 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013608 | 220008038 | 1.67 | 53.9 | Curative (C) | 2017-05-12 | 2017-05-16 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220030633 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013609 | 220008039 | 1.91 | 77.7 | null | 2013-06-29 | 2013-06-29 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | N | 220030640 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013610 | 220008039 | null | 55.1 | Curative (C) | 2012-12-23 | 2014-01-02 | Dasatinib | 99 | N | 220030640 | DASATINIB |
| 220013611 | 220017858 | 1.62 | 69.7 | null | 2014-01-28 | 2014-01-28 | Dasatinib | N | N | 220030648 | DASATINIB |
| 220013612 | 220017858 | 1.93 | 90 | Disease modification (D) | 2012-02-15 | 2014-11-20 | Rituximab | N | N | 220030648 | RITUXIMAB |
| 220013613 | 220017858 | 1.58 | 64.9 | Curative (C) | 2017-09-08 | 2017-11-24 | AML18 PILOT TRIAL | Y | N | 220030648 | PILOT TRIAL |
| 220013614 | 220008042 | 1.73 | null | null | 2014-03-14 | 2014-03-14 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220030652 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013615 | 220014402 | null | 99.4 | Curative (C) | null | 2017-11-23 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220030653 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013616 | 220008043 | 1.66 | null | Disease modification (D) | null | 2014-05-10 | Rituximab | 02 | null | 220030656 | RITUXIMAB |
| 220013617 | 220008044 | 1.6 | 64.9 | Curative (C) | 2013-03-04 | 2013-03-06 | AML18 PILOT TRIAL | Y | N | 220030661 | PILOT TRIAL |
| 220013618 | 220008047 | 1.77 | null | Curative (C) | 2017-01-15 | 2017-01-18 | Dasatinib | 02 | N | 220030664 | DASATINIB |
| 220013619 | 220008047 | 1.63 | 72 | Curative (C) | null | 2016-12-14 | AML 18 TRIAL | Y | N | 220030664 | AML18 TRIAL |
| 220013620 | 220019799 | 1.64 | 52 | Curative (C) | 2014-08-01 | 2014-08-06 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220030678 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220013621 | 220008048 | 1.52 | 78.6 | Not known (9) | 2015-09-30 | 2015-10-12 | Dasatinib | N | N | 220030685 | DASATINIB |
| 220013622 | 220017861 | 1.58 | 69.4 | Curative (C) | 2013-05-26 | 2013-05-26 | AML 18 TRIAL | N | N | 220030685 | AML18 TRIAL |
| 220013623 | 220017861 | 1.76 | 78.05 | Curative (C) | 2012-12-10 | 2013-03-11 | AML 18 TRIAL | Y | null | 220030685 | AML18 TRIAL |
| 220013624 | 220008053 | 0 | 82.8 | Curative (C) | 2013-08-28 | 2013-11-25 | AML18 PILOT TRIAL | Y | null | 220030693 | PILOT TRIAL |
| 220013625 | 220017862 | null | 72.8 | Curative (C) | 2017-05-02 | 2017-09-18 | Rituximab (Maintenance) | N | null | 220030693 | RITUXIMAB |
| 220013626 | 220014407 | 1.63 | null | Disease modification (D) | 2015-05-11 | 2016-08-07 | Dasatinib | 02 | N | 220030696 | DASATINIB |
| 220013627 | 220008055 | 1.72 | 68.5 | Curative (C) | 2014-12-29 | 2015-01-20 | Rituximab | N | N | 220030706 | RITUXIMAB |
| 220013628 | 220008055 | null | 107.35 | Curative (C) | 2017-05-29 | 2017-07-09 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 01 | N | 220030706 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |